MedPath

Study held to see the effect of Dashamooladi tablet in tingling sensation and/or numbness

Phase 2/3
Completed
Conditions
Disorder of the autonomic nervoussystem, unspecified. Ayurveda Condition: JHINJHINI VATA,
Registration Number
CTRI/2023/02/049994
Lead Sponsor
Dr Bhavya Khurana
Brief Summary

The aim of the study is to see the effectiveness of Dashamooladi Ghanavati in the management of Jhinjhini Vata (Peripheral Neuropathy). The study will be conducted with 30 patients showing signs and symptoms of peripheral neuropathy - tingling sensation and/or numbness. They will be administered 2 tablets (each 500 mg) twice a day along with warm water, for a duration of 14 days. Follow ups will be done on 7th and 14th day. Final conclusion will be drawn on the basis of proper statistical methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria
    1. Age between 18-70 years of both genders.
    1. Patients with the symptoms of tingling sensation and/or numbness.
    1. Patients who are not taking any other medications for tingling sensations and/or numbness.
Exclusion Criteria
    1. Known pregnant and lactating woman.
    1. Patients with Pulmonary Tuberculosis , Cardiac complications, Immuno-compromised, Renal complications, Malignancies etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To access the effect of Dashamooladi Ghanavati in the management of Jhinjhini Vata14 days study with 2 follow ups (0,7,14)
Secondary Outcome Measures
NameTimeMethod
1) To study the new etiological factors of Jhinjhini Vata in present era.2) To study the ayurvedic pathogenesis of Jhinjhini Vata.

Trial Locations

Locations (1)

Dr D Y Patil College Of Ayurved and Research Centre

🇮🇳

Pune, MAHARASHTRA, India

Dr D Y Patil College Of Ayurved and Research Centre
🇮🇳Pune, MAHARASHTRA, India
Dr Bhavya Khurana
Principal investigator
8800655055
bhavyakhurana1997bk@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.